Evidence method
Level · gp.fundamentals.capex_revenue_ratio
45.73% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
IBRX · Sep 30, 2024
ImmunityBio, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001326110-24-000111General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1617.47% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
7346.34% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
32.07% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
100.00% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-1314.33% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
826.12% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
122.65% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History9 statesHistory building
Period transition
What moved in the state?
- Previous
- 69.15%
- Current
- 45.73%
- Delta
- -23.42%
- Previous
- -9584.24%
- Current
- -1617.47%
- Delta
- 7966.77%
- Previous
- 172.97%
- Current
- 32.07%
- Delta
- -140.90%
- Previous
- -9487.39%
- Current
- -1314.33%
- Delta
- 8173.06%
- Previous
- 4883.38%
- Current
- 826.12%
- Delta
- -4057.26%
- Previous
- 920.63%
- Current
- 122.65%
- Delta
- -797.98%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · IBRX Fundamental State →Has State · ImmunityBio, Inc. →Transitioned To · IBRX Fundamental State →Transitioned To · IBRX CAPEX_INTENSITY_DECREASED →Transitioned To · IBRX CASH_GENERATION_INCREASED →Transitioned To · IBRX INVENTORY_PRESSURE_DECREASED →Transitioned To · IBRX PROFITABILITY_INCREASED →Transitioned To · IBRX R_AND_D_INTENSITY_DECREASED →Transitioned To · IBRX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.